<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="178">
  <stage>Registered</stage>
  <submitdate>11/08/2005</submitdate>
  <approvaldate>26/08/2005</approvaldate>
  <actrnumber>ACTRN12605000231640</actrnumber>
  <trial_identification>
    <studytitle>A clinical trial of dexmedetomidine or remifentanil sedation for awake fibreoptic intubation</studytitle>
    <scientifictitle>A clinical trial of dexmedetomidine or remifentanil sedation for awake fibreoptic intubation</scientifictitle>
    <utrn />
    <trialacronym>STOPIT</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Anaesthesia</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Dexmedetomidine 0.7 mcg/kg then 0.4 mcg/kg/h until completion of procedure</interventions>
    <comparator>IV remifentanil 0.05 mcg/kg/min from arrival in operating room until intubation</comparator>
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Efficacy of sedation</outcome>
      <timepoint>Assessed by patient response at time of intubation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient satisfaction</outcome>
      <timepoint>at 24 hours post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Anaesthetist satisfaction</outcome>
      <timepoint>at end of procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Requirement for adjustment of infusion rate</outcome>
      <timepoint>during procedure</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Awake fibreoptic intubation, no contraindication to remifentanil or dexmedetomidine.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Chronic alpha-2 agonist or opioid therapy, allergy or previous adverse reaction to study drugs, uncontrolled hypertension, heart &lt;50, 2nd or 3rd degree heart block, severe ventricular, renal, hepatic or respiratory dysfuction, pregnancy or lactation.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelope</concealment>
    <sequence>Computer generated</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>30/11/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Sarah Harper</primarysponsorname>
    <primarysponsoraddress>Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Wellington St Perth WA 6000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Abbott Australasia</fundingname>
      <fundingaddress>Locked bag 5016, Botany NSW 1455</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Royal Perth Hospital</sponsorname>
      <sponsoraddress>Wellington St, Perth WA 6000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Perth Hospital</ethicname>
      <ethicaddress>Wellington St, Perth WA 6000</ethicaddress>
      <ethicapprovaldate>30/10/2004</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Shauna Fatovich</name>
      <address>Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street
Perth WA 6000</address>
      <phone>+61 8 92241036</phone>
      <fax />
      <email>shauna.fatovich@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Michael Paech</name>
      <address>Department of Anaesthesia and Pain  Medicine
Royal Perth Hospital
Wellington Street
Perth WA 6000</address>
      <phone>+61 8 92241036</phone>
      <fax />
      <email>michael.paech@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>